Skip to content

The effect of propacetamol to intrapulmonary shunt, thromboxane A2 and prostacyclin during one-lung ventilation

The effect of propacetamol to intrapulmonary shunt, thromboxane A2 and prostacyclin during one-lung ventilation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017966
Enrollment
Unknown
Registered
2018-08-25
Start date
2018-08-24
Completion date
Unknown
Last updated
2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung disease

Interventions

Group 1:propacetamol 1 g iv
Group 2:saline 15 ml iv

Sponsors

Wuxi People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 18-75 years old, despite of man or woman, undergoing one-lung ventilation, patients undergoing lobectomy of lung or mediastinal tumor resection under thoracoscope, more than an hour of operation time

Exclusion criteria

Exclusion criteria: with hypertension and heart disease, respiratory disease, psychological and nervous disease, abnormal liver and kidney function, pregnancy, less than an hour of operation time.

Design outcomes

Primary

MeasureTime frame
blood gas analysis;MAP;HR;SpO2;ETCO2;Ppeak;Vt;Bis;f;thromboxane A2;prostacyclin;

Countries

China

Contacts

Public ContactGu Zhengfeng

Wuxi People's Hospital

gzf110677@163.com+86 13861789062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026